Free Trial
NASDAQ:BCPC

Balchem (BCPC) Stock Price, News & Analysis

$168.63
-3.27 (-1.90%)
(As of 09/6/2024 ET)
Today's Range
$167.01
$172.73
50-Day Range
$154.10
$181.56
52-Week Range
$110.74
$186.03
Volume
130,426 shs
Average Volume
106,129 shs
Market Capitalization
$5.47 billion
P/E Ratio
47.64
Dividend Yield
0.23%
Price Target
$185.00

Balchem MarketRank™ Stock Analysis

Analyst Rating
Buy
3.00 Rating Score
Upside/​Downside
9.7% Upside
$185.00 Price Target
Short Interest
Bearish
1.63% of Float Sold Short
Dividend Strength
Strong
Based on Four Factors
Sustainability
-1.54
Upright™ Environmental Score
News Sentiment
N/A
Insider Trading
Selling Shares
$1.40 M Sold Last Quarter
Proj. Earnings Growth
16.41%
From $3.96 to $4.61 Per Share

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

4.07 out of 5 stars

Basic Materials Sector

60th out of 180 stocks

Chemicals & Allied Products Industry

4th out of 14 stocks

BCPC stock logo

About Balchem Stock (NASDAQ:BCPC)

Balchem Corporation develops, manufactures, and markets specialty performance ingredients and products for the nutritional, food, pharmaceutical, animal health, medical device sterilization, plant nutrition, and industrial markets worldwide. It operates through three segments: Human Nutrition and Health, Animal Nutrition and Health, and Specialty Products. The Human Nutrition & Health segment supplies ingredients in the food and beverage industry. Its products include spray dried and emulsified powders, extrusion and agglomeration, blended lipid systems, liquid flavor delivery systems, juice and dairy bases, chocolate systems, and cereal systems, as well as ice cream bases and variegates. This segment also offers specialty vitamin K2; microencapsulation solutions for various applications; and human grade choline nutrients and mineral amino acid chelated products for nutrition and health applications. The Animal Nutrition & Health segment provides microencapsulated products to enhance health and milk production, and delivering nutrient supplements in ruminant animals; chelation technology, which offers enhanced nutrient absorption for various species of production and companion animals; methylsulfonylmethane; and choline chloride, a nutrient for monogastric animal health. The Specialty Products segment distributes ethylene oxide and ammonia primarily for use in the health care industry; and single use canisters for sterilizing re-usable devices. This segment also markets and sells propylene oxide, a fumigant to aid in the control of insects and microbiological spoilage, as well as to reduce bacterial and mold contamination in shell and processed nut meats, processed spices, cacao beans, cocoa powder, raisins, figs, and prunes; and chelated minerals for high value crops. It sells its products through sales force, independent distributors, and sales agents. The company was incorporated in 1967 and is headquartered in Montvale, New Jersey.

BCPC Stock Price History

BCPC Stock News Headlines

EXPOSED: Hotspot Dates for popular stocks
Did you know almost every stock in the market has multiple “Hotspot Dates”? They indicate when the stock has gone up on the same dates… at the same time… FOR DECADES For example, have you ever traded a stock called Constellation Energy (ticker: CEG)? Maybe not… Energy stocks haven’t received much love over the past 12 months. But anybody who knew about the “Hotspot Date” during the last week in January…
DD Aug 2024 69.000 put (DD240823P00069000)
BCPC Sep 2024 180.000 put (BCPC240920P00180000)
DD Jun 2025 52.500 put
DD Jan 2025 90.000 put
EXPOSED: Hotspot Dates for popular stocks
Did you know almost every stock in the market has multiple “Hotspot Dates”? They indicate when the stock has gone up on the same dates… at the same time… FOR DECADES For example, have you ever traded a stock called Constellation Energy (ticker: CEG)? Maybe not… Energy stocks haven’t received much love over the past 12 months. But anybody who knew about the “Hotspot Date” during the last week in January…
BCPC Aug 2024 155.000 put
Balchem Q2 2024 Earnings Preview
BCPC Aug 2024 130.000 put (BCPC240816P00130000)
See More Headlines
Receive BCPC Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Balchem and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
7/26/2024
Today
9/07/2024
Next Earnings (Estimated)
10/25/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Industry
Chemicals & allied products
Sub-Industry
Specialty Chemicals
Current Symbol
NASDAQ:BCPC
CUSIP
05766520
CIK
9326
Employees
1,302
Year Founded
1967

Price Target and Rating

Average Stock Price Target
$185.00
High Stock Price Target
$185.00
Low Stock Price Target
$185.00
Potential Upside/Downside
+9.7%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
1 Analysts

Profitability

Net Income
$108.54 million
Pretax Margin
15.85%

Debt

Sales & Book Value

Annual Sales
$932.39 million
Cash Flow
$4.83 per share
Book Value
$34.29 per share

Miscellaneous

Free Float
32,018,000
Market Cap
$5.47 billion
Optionable
Optionable
Beta
0.68

Social Links

The Next 7 Blockbuster Stocks for Growth Investors Cover

Wondering what the next stocks will be that hit it big, with solid fundamentals? Click the link below to learn more about how your portfolio could bloom.

Get This Free Report

Key Executives

  • Mr. Theodore L. HarrisMr. Theodore L. Harris (Age 59)
    Chairman, CEO & President
    Comp: $2.42M
  • Mr. Carl Martin Bengtsson (Age 46)
    Executive VP, CFO, Treasurer & GM of Animal Nutrition and Health
    Comp: $887.37k
  • Ms. Hatsuki Miyata (Age 48)
    Executive VP, General Counsel & Secretary
    Comp: $691.42k
  • Mr. Martin Luther Reid (Age 56)
    Senior VP & Chief Supply Chain Officer
    Comp: $704.09k
  • Mr. Frederic Boned (Age 46)
    Senior VP and GM of Human Nutrition & Health
    Comp: $712.2k
  • Mr. William A. Backus CPA (Age 58)
    VP & Chief Accounting Officer
    Comp: $560.79k
  • Mr. Michael R. Sestrick Ph.D. (Age 60)
    Senior VP & CTO
  • Mr. Jonathan H. Griffin (Age 48)
    Senior Vice President of Corporate Development
    Comp: $624.01k
  • Mr. M. Brent Tignor (Age 45)
    Senior VP & Chief Human Resources Officer
  • Mr. Job L. van Gunsteren (Age 48)
    Senior VP & GM of Specialty Products

BCPC Stock Analysis - Frequently Asked Questions

How have BCPC shares performed this year?

Balchem's stock was trading at $148.75 at the start of the year. Since then, BCPC shares have increased by 13.4% and is now trading at $168.63.
View the best growth stocks for 2024 here
.

How were Balchem's earnings last quarter?

Balchem Co. (NASDAQ:BCPC) posted its quarterly earnings results on Friday, July, 26th. The basic materials company reported $0.98 EPS for the quarter, topping the consensus estimate of $0.95 by $0.03. The basic materials company had revenue of $234.08 million for the quarter, compared to analysts' expectations of $241.26 million. Balchem had a net margin of 12.52% and a trailing twelve-month return on equity of 10.94%.

What is Dino A. Rossi's approval rating as Balchem's CEO?

25 employees have rated Balchem Chief Executive Officer Dino A. Rossi on Glassdoor.com. Dino A. Rossi has an approval rating of 85% among the company's employees. 62.0% of employees surveyed would recommend working at Balchem to a friend.

Does Balchem have any subsidiaries?

Balchem subsidiaries include these companies: Zumbro River Brand Inc., Chemogas Holding NV, Bioscreen technologies, Innovative Food Processors, Chol-Mix Kft, Albion Laboratories Inc., SensoryEffects, and others.

Who are Balchem's major shareholders?

Top institutional investors of Balchem include APG Asset Management N.V. (9.27%), Conestoga Capital Advisors LLC (3.56%), Dimensional Fund Advisors LP (2.15%) and Clearbridge Investments LLC (1.40%). Insiders that own company stock include Theodore L Harris, David B Fischer, Gunsteren Job Leonard Van, William A Backus and Michael Robert Sestrick.
View institutional ownership trends
.

How do I buy shares of Balchem?

Shares of BCPC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

What other stocks do shareholders of Balchem own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Balchem investors own include Ecolab (ECL), CVS Health (CVS), AbbVie (ABBV), Johnson & Johnson (JNJ), Lowe's Companies (LOW), Altria Group (MO) and NVIDIA (NVDA).

This page (NASDAQ:BCPC) was last updated on 9/7/2024 by MarketBeat.com Staff

From Our Partners